In this episode, we discuss CVS's move toward transparent pricing, the pharmaceutical industry's embrace of data science, Google's latest AI tool, the success of small VC funds, and an outlook on healthcare for 2024.
Please check out our Episode...
In this episode, we discuss CVS's move toward transparent pricing, the pharmaceutical industry's embrace of data science, Google's latest AI tool, the success of small VC funds, and an outlook on healthcare for 2024.
Please check out our Episode Resources below:
------🔎RESOURCES🔎
Biden Announces Actions to Lower Health Care and Drug Costs (White House) // https://bit.ly/3NktJ5h
CVS Says It Will Change the Way Its Pharmacies Are Paid (NYT) // https://bit.ly/46Q7yei
Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments (WSJ) // https://on.wsj.com/3GyJORd
J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off? (WSJ) // https://on.wsj.com/3ta2svo
AstraZeneca launches Evinova, a health-tech business to accelerate innovation (MobiHealth) // https://bit.ly/48a1Uo9
Google Gemini Launches (CNET) // https://cnet.co/3NlKj4D
Meta and IBM Launch AI Alliance (WSJ) // https://on.wsj.com/3Ni6NDy
Big VC Funds Are Underperforming Smaller Ones and Their Future Is Dim (Institutional Investor) // https://bit.ly/3RxYKFp
Deloitte says healthcare leaders should prepare for a tough 2024 (Fierce Healthcare) // https://bit.ly/3RCEO4l
Healthcare companies may have to default in 2024,...